Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market buy President and CEO bought 10,000 shares at $1.93 ($19,254)
  2. SC 13D/A Stake Beneficial Ownership Report
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 8-K Event Results of operations · Other events
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 8-K Event Shareholder vote results
  14. SC 13G Stake Amended Statement of Ownership
  15. 4 Open-market buy President and CEO bought 35,714 shares at $2.80 ($99,999)
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. DEFA14A Proxy Proxy Materials
  20. DEF 14A Proxy Proxy Statement

Page 13 of 30 · 584 filings